Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
22. KONGRES EURÓPSKEJ HEMATOLOGICKEJ ASOCIÁCIE (EHA). MADRID 22. – 25. 6. 2017
15 októbra, 2020 7:25 pmAnémie Na tohtoročnom kongrese Európskej hematologickej spoločnosti (EHA) v Madride nebola venovaná veľká pozornosť problematike anémií. Napriek tomu sa objavili zaujímavé prednášky...
COMBINATION TREATMENT OF RITUXIMAB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE FOR WARM AUTOIMMUNE HEMOLYTIC ANEMIA
13 októbra, 2020 5:57 pmAuthor(s): Caroline Piatek, Hillel Bocian, Casey O’Connell, et al. Abstract: PS1139 Session topic: 29. Enzymopathies, membranopathies and other...
RA101495, A SUBCUTANEOUSLY-ADMINISTERED PEPTIDE INHIBITOR OF COMPLEMENT COMPONENT C5, FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: PHASE 2 RESULTS
13 októbra, 2020 5:57 pmAuthor(s): Anita Hill, Hubert Schrezenmeier, Peter Hillmen, et al. Abstract: PF305 Session topic: 12. Bone marrow failure syndromes...
CLINICAL AND MORPHOLOGIC PREDICTORS OF OUTCOME IN APLASTIC ANEMIA PATIENTS TREATED WITH ELTROMBOPAG
13 októbra, 2020 5:57 pmAuthor(s): Bruno Fattizzo, Nana Benson-Quarm, Anita Hill, et al. Abstract: PF307 Session topic: 12. Bone marrow failure syndromes...
ANÉMIE – NOVINKY Z KONGRESU
13 októbra, 2020 5:57 pmV dňoch 14. – 17. júna 2018 sa uskutočnil v Štokholme 23. kongres Európskej hematologickej asociácie (EHA). V bohatom odbornom programe sa objavili...
Správa zo sympózia
13 októbra, 2020 5:57 pmNa kongrese EHA 2018 bol myeloproliferatívnym chorobám venovaný značný priestor v rámci edukačných a satelitných sympózií, vedeckej pracovnej skupiny a taktiež v posterovej sekcii. V rámci...
FREQUENT IMMUNOGLOBULIN REARRANGEMENT, JAK1/2 INHIBITION AND AGGRESSIVE B-CELL LYMPHOMA DEVELOPMENT IN PATIENTS WITH MYELOFIBROSIS
13 októbra, 2020 5:56 pmAuthor(s): Veronika Sexl, Edit Porpaczy, Sabrina Tripolt, et al. Abstract: S130 Session topic: 16. Myeloproliferative neoplasms – Clinical...
COMPARATIVE PERFORMANCE OF PROGNOSTIC SYSTEMS IN PATIENTS WITH MYELOFIBROSIS SECONDARY TO PV AND ET AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION
13 októbra, 2020 5:56 pmAuthor(s): Nico Gagelmann, Diderik-Jan Eikema, Linda Koster, et al. Abstract: S129 Session topic: 16. Myeloproliferative neoplasms – Clinical...
RESURRECTING RESPONSE TO RUXOLITINIB: A PHASE I STUDY TESTING THE COMBINATION OF RUXOLITINIB AND THE PI3K DELTA INHIBITOR UMBRALISIB IN RUXOLITINIB-EXPERIENCED MYELOFIBROSIS
13 októbra, 2020 5:56 pmAuthor(s): Tamara Moyo, Jeanne Palmer, Yi Huang, et al. Abstract: S133 Session topic: 16. Myeloproliferative neoplasms – Clinical...
INTERIM ANALYSIS OF THE DALIAH TRIAL – A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN MPN PATIENTS
13 októbra, 2020 5:56 pmAuthor(s): Trine Alma Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, et al. Abstract: S131 Session topic: 16. Myeloproliferative...